Radiosensitizing drugs in relation to individualized treatment.
D000477:Alkylating Agents / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D066298:In Vitro Techniques; D008920:Misonidazole / Q000008:administration & dosage; D009369:Neoplasms / Q000532:radiotherapy*; D009420:Nervous System / Q000187:drug effects; D009593:Nitroimidazoles / Q000627:therapeutic use; D011836:Radiation Tolerance; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D013439:Sulfhydryl Reagents / Q000627:therapeutic use
D000477:Alkylating Agents; D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents; D013439:Sulfhydryl Reagents; D008920:Misonidazole